These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 9832950

  • 1. Injection of SCH 23390 into the ventral tegmental area blocks the development of neurochemical but not behavioral sensitization to cocaine.
    Steketee JD.
    Behav Pharmacol; 1998 Feb; 9(1):69-76. PubMed ID: 9832950
    [Abstract] [Full Text] [Related]

  • 2. Application of a protein synthesis inhibitor into the ventral tegmental area, but not the nucleus accumbens, prevents behavioral sensitization to cocaine.
    Sorg BA, Ulibarri C.
    Synapse; 1995 Jul; 20(3):217-24. PubMed ID: 7570353
    [Abstract] [Full Text] [Related]

  • 3. Neutralization of neutrophin-3 in the ventral tegmental area or nucleus accumbens differentially modulates cocaine-induced behavioral plasticity in rats.
    Freeman AY, Pierce RC.
    Synapse; 2002 Nov; 46(2):57-65. PubMed ID: 12211082
    [Abstract] [Full Text] [Related]

  • 4. Injection of SCH 23390, but not 7-hydroxy-DPAT, into the ventral tegmental area blocks the acute motor-stimulant response to cocaine.
    Steketee JD, Braswell BC.
    Behav Pharmacol; 1997 Feb; 8(1):58-64. PubMed ID: 9833001
    [Abstract] [Full Text] [Related]

  • 5. Repeated intra-ventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge.
    Pierce RC, Born B, Adams M, Kalivas PW.
    J Pharmacol Exp Ther; 1996 Jul; 278(1):384-92. PubMed ID: 8764374
    [Abstract] [Full Text] [Related]

  • 6. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine.
    Pierce RC, Kalivas PW.
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1019-29. PubMed ID: 7473128
    [Abstract] [Full Text] [Related]

  • 7. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization.
    Sorg BA, Li N, Wu WR.
    J Pharmacol Exp Ther; 2001 May; 297(2):501-8. PubMed ID: 11303036
    [Abstract] [Full Text] [Related]

  • 8. Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine.
    Bjijou Y, Stinus L, Le Moal M, Cador M.
    J Pharmacol Exp Ther; 1996 May; 277(2):1177-87. PubMed ID: 8627530
    [Abstract] [Full Text] [Related]

  • 9. Acupuncture attenuates cocaine-induced expression of behavioral sensitization in rats: possible involvement of the dopaminergic system in the ventral tegmental area.
    Lee B, Han SM, Shim I.
    Neurosci Lett; 2009 Jan 09; 449(2):128-32. PubMed ID: 18992788
    [Abstract] [Full Text] [Related]

  • 10. Contribution of dihydro-beta-erythroidine sensitive nicotinic acetylcholine receptors in the ventral tegmental area to cocaine-induced behavioral sensitization in rats.
    Champtiaux N, Kalivas PW, Bardo MT.
    Behav Brain Res; 2006 Mar 15; 168(1):120-6. PubMed ID: 16313978
    [Abstract] [Full Text] [Related]

  • 11. Neurochemical and behavioral responses to cocaine in adult male rats with neonatal isolation experience.
    Kosten TA, Zhang XY, Kehoe P.
    J Pharmacol Exp Ther; 2005 Aug 15; 314(2):661-7. PubMed ID: 15845857
    [Abstract] [Full Text] [Related]

  • 12. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine.
    Kalivas PW, Alesdatter JE.
    J Pharmacol Exp Ther; 1993 Oct 15; 267(1):486-95. PubMed ID: 8229779
    [Abstract] [Full Text] [Related]

  • 13. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
    Altier N, Stewart J.
    J Pharmacol Exp Ther; 1998 Apr 15; 285(1):208-15. PubMed ID: 9536012
    [Abstract] [Full Text] [Related]

  • 14. Repeated injection of GBR 12909, but not cocaine or WIN 35,065-2, into the ventral tegmental area induces behavioral sensitization.
    Steketee JD.
    Behav Brain Res; 1998 Dec 15; 97(1-2):39-48. PubMed ID: 9867229
    [Abstract] [Full Text] [Related]

  • 15. Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to antinociceptive effect of morphine.
    Reisi Z, Bani-Ardalan M, Zarepour L, Haghparast A.
    Pharmacol Biochem Behav; 2014 Mar 15; 118():16-21. PubMed ID: 24418216
    [Abstract] [Full Text] [Related]

  • 16. Microinjections of a dopamine D1 receptor antagonist into the ventral tegmental area block the expression of cocaine conditioned place preference in rats.
    Galaj E, Manuszak M, Arastehmanesh D, Ranaldi R.
    Behav Brain Res; 2014 Oct 01; 272():279-85. PubMed ID: 25017572
    [Abstract] [Full Text] [Related]

  • 17. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
    Dietz DM, Tapocik J, Gaval-Cruz M, Kabbaj M.
    Physiol Behav; 2005 Oct 15; 86(3):347-55. PubMed ID: 16126238
    [Abstract] [Full Text] [Related]

  • 18. Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on the locomotor and sensitizating effects of cocaine in rats.
    Przegaliński E, Papla I, Siwanowicz J, Filip M.
    Eur Neuropsychopharmacol; 2004 May 15; 14(3):217-25. PubMed ID: 15056481
    [Abstract] [Full Text] [Related]

  • 19. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
    Tolliver BK, Newman AH, Katz JL, Ho LB, Fox LM, Hsu K, Berger SP.
    J Pharmacol Exp Ther; 1999 Apr 15; 289(1):110-22. PubMed ID: 10086994
    [Abstract] [Full Text] [Related]

  • 20. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine.
    Tolliver BK, Ho LB, Fox LM, Berger SP.
    J Pharmacol Exp Ther; 1999 Apr 15; 289(1):38-47. PubMed ID: 10086985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.